Skip to main content
Explore URMC

URMC Logo

Edith M. Lord, Ph.D.

Contact Information

Phone Numbers

Appointment: (585) 276-3000

Biography

Professional Background

Dr. Edith Lord is the Senior Associate Dean for Graduate Education and Postdoctoral Affairs at the School of Medicine and Dentistry. Dr. Lord received her BA degree in microbiology from the University of Kansas in 1970 and a Ph.D degree in immunology from the University of California at San Diego in 1975. She was a postdoctoral fellow at the University of California at San Francisco. Dr. Lord leads the School of Medicine and Dentistry's Ph.D., postdoctoral and master's degree programs. As a faculty member since 1976, Dr. Lord has demonstrated excellence as a scientist and dedication to her position as Senior Associate Dean.

From 2006-2008, Dr. Lord led the graduate program in the Department of Microbiology and Immunology. She also directs the school's Post-baccalaureate Research and Education Program (PREP), which encourages underrepresented minorities to pursue a research doctorate and prepares them for careers as scientists and leaders in the biomedical community.

In her research, Dr. Lord focuses on the immune responses that can control tumor development and also studies the unique microenvironment present within growing tumors. She has published, as author and co-author, more than 100 scientific articles and continues her passion for research today.

Credentials

Faculty Appointments

Education

1970
BA | University of Kansas
Microbiology

1975
PhD | Univ of Cal San Diego
Immunology

Patents

Title: Human Glandular Kallikrein (HK2)-Specific Monoclonal Antibodies that Enhance or Inhibit the Enzymatic Activity of HK2
U.S. Serial #: 10/491,761
Filed: Oct 03, 2002
Invented By: TerrenceFisher, JohnFrelinger, EdithLord, Mary AnnNocera-March

Publications

Journal Articles

1/2015
Gerber SA, Cummings RJ, Judge JL, Barlow ML, Nanduri J, Johnson DE, Palis J, Pentland AP, Lord EM, Ryan JL. "Interleukin-12 preserves the cutaneous physical and immunological barrier after radiation exposure." Radiation research.. 2015 Jan 0; 183(1):72-81. Epub 2015 Jan 07.

7/2014
Martin DK, Uckermann O, Bertram A, Liebner C, Hendruschk S, Sitoci-Ficici KH, Schackert G, Lord EM, Temme A, Kirsch M. "Differential growth inhibition of cerebral metastases by anti-angiogenic compounds." Anticancer research.. 2014 Jul 0; 34(7):3293-302.

5/15/2014
Gerber SA, Lim JY, Connolly KA, Sedlacek AL, Barlow ML, Murphy SP, Egilmez NK, Lord EM. "Radio-responsive tumors exhibit greater intratumoral immune activity than nonresponsive tumors." International journal of cancer.. 2014 May 15; 134(10):2383-92. Epub 2013 Nov 11.

VIEW ALL PUBLICATIONS